Inventor
KREITER SEBASTIAN
DE23 patents
⚠️ This page may combine multiple inventors who share the name “KREITER SEBASTIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIONTECH RNA PHARMACEUTICALS GMBH
9 patentsUS10576146B2Mar 3, 2020
Particles comprising a shell with RNA
BIONTECH RNA PHARMACEUTICALS GMBH13 citations92
US10485884B2Nov 26, 2019
RNA formulation for immunotherapy
BIONTECH RNA PHARMACEUTICALS GMBH16 citations91
US10669322B2Jun 2, 2020
RNA molecules encoding cytokine fusion proteins and methods of use thereof
BIONTECH RNA PHARMACEUTICALS GMBH4 citations72
US11045418B2Jun 29, 2021
Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell
BIONTECH RNA PHARMACEUTICALS GMBH3 citations71
US10301368B2May 28, 2019
Cytokine fusion proteins
BIONTECH RNA PHARMACEUTICALS GMBH4 citations68
US11156617B2Oct 26, 2021
Predicting T cell epitopes useful for vaccination
BIONTECH RNA PHARMACEUTICALS GMBH3 citations65
US11337922B2May 24, 2022
Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell
BIONTECH RNA PHARMACEUTICALS GMBH0 citations60
US11318195B2May 3, 2022
Formulation for administration of RNA
BIONTECH RNA PHARMACEUTICALS GMBH1 citations57
US10808019B2Oct 20, 2020
Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands
BIONTECH RNA PHARMACEUTICALS GMBH0 citations46
BioNTech SE
6 patentsUS11559587B2Jan 24, 2023
RNA formulation for immunotherapy
BioNTech SE3 citations70
US11298426B2Apr 12, 2022
Recombinant vaccines and use thereof
BioNTech SE0 citations62
US12385049B2Aug 12, 2025
Modification of RNA, producing an increased transcript stability and translation efficiency
BioNTech SE0 citations61
US11660338B2May 30, 2023
Particles comprising a shell with RNA
BioNTech SE0 citations60
US12150947B2Nov 26, 2024
Formulation for administration of RNA
BioNTech SE0 citations56
US11701413B2Jul 18, 2023
RNA for treatment of autoimmune diseases
BioNTech SE0 citations55
SAHIN UGUR
3 patentsUS9476055B2Oct 25, 2016
Modification of RNA, producing an increased transcript stability and translation efficiency
SAHIN UGUR29 citations93
US10738355B2Aug 11, 2020
Individualized vaccines for cancer
SAHIN UGUR41 citations90
US9486519B2Nov 8, 2016
Use of FLT3 ligand for enhancing immune responses in RNA immunization
SAHIN UGUR15 citations80